How do Herceptin (trastuzumab) and Perjeta (pertuzumab) work together?

How do Herceptin and Perjeta work together for breast cancer?

Herceptin and Perjeta work together by blocking the HER2 receptor, but instead of blocking the HER2 receptor in the same place, they each block separate areas, which means that when used together they are more effective at reducing breast cancer cell growth.

How do they work?

Herceptin (generic name: trastuzumab) and Perjeta (generic name: pertuzumab) are HER2 inhibitors so work by binding to HER2 receptor which:

• Slows or reduces breast cancer growth.
• Marks the cancer cell so that immune cells will recognize it as a cancer cell and destroy it.

Cancer occurs when cells grow in an uncontrolled fashion, so that the tumor can grow and spread.
How fast our cells grow, divide and repair themselves is controlled by receptors on the cells, when the receptor gets a signal the cell grows and divides.

Slowing breast cancer growth

• In HER2 positive (HER2 +) breast cancer there are a lot more HER2 receptors on the cells than usual, so when there is a signal for growth all of the HER2 receptors give the cell the same message to grow and multiply, because there are so many messages it triggers the cancer cells grow and multiply too fast and too often.
• Both Herceptin and Perjeta attach to the HER2 receptor which blocks the message telling the breast cancer cell to grow and multiply.
• As the message is blocked it means that the cancer growth slows or stops.

Destroying breast cancer cells

• Once Herceptin or Perjeta binds to the HER2 receptor on the breast cancer cell it also makes the cancer cell a target for the immune cells, who will recognize it and destroy the breast cancer cell.

Treatment Plans.

• For specific types of breast cancer both drugs are given as part of a treatment plan in combination with other medications.

Click here for more information about Breast Cancer: Treatment and Prevention Options

Bottom Line:

• Herceptin and Perjeta both block the HER2 receptor on breast cancer cells.
• Binding to the HER2 receptor causes the breast cancer growth to be reduced and marks the breast cancer cells as a target for the immune cells, which destroy them.
• By blocking the HER2 receptor in two separate areas means both drugs are attacking the HER2 receptor in two places, so that together they are more successful at suppressing tumor growth.

Related questions

• What are monoclonal antibodies?
• What are biosimilar drugs and how do they compare to biologics?
• How soon can you start chemo after port placement?

Read next

See also:

Related medical questions

• How long can I stay on Herceptin?
• What are the biosimilars of Herceptin?
• What are biologic drugs and how do they work?
• What biosimilars have been approved in the United States?
• What is Herceptin? Is Herceptin a chemo drug? How does it work?
• How long does Herceptin stay in your body?
• How effective is Herceptin for Breast & Gastric Cancer?
• What is the difference between Herceptin and Herceptin Hylecta?
• Does Herceptin (trastuzumab) stop menstrual periods?
• Do Herceptin (trastuzumab) injections hurt?
• What is the difference between Herzuma and Herceptin?
• What is the difference between Ogivri and Herceptin?
• How is Herceptin Injection and Herceptin Hylecta administered?

Drug information

• Herceptin (12 reviews)
• Trastuzumab (12 reviews)
• Perjeta
• Pertuzumab

Related support groups

• Herceptin (21 questions, 32 members)
• Trastuzumab (15 questions, 4 members)
• Perjeta (8 questions, 6 members)
• Pertuzumab (4 questions, 4 members)
• Cancer (190 questions, 645 members)
• Breast Cancer (130 questions, 311 members)
• Breast Cancer, Metastatic (58 questions, 80 members)
• Breast Cancer - Adjuvant (33 questions, 22 members)

Medical Disclaimer